ProgramStand up to Cancer (SU2C) Canada Cancer Stem Cell Dream Team
For More Information
Please review the Program Guidelines for additional information on
- Research Project criteria;
- eligibility criteria for applicants;
- the evaluation and selection of proposals; and,
- information relating to the requirements for submitting full applications.
The successful Cancer Stem Cell Dream Team will focus their research on the role of cancer stem cells and stem cell programs on resistance and treatment failure in cancer, and will include genomic approaches central to their methodology. The Cancer Stem Cell Dream Team will bring together key stakeholders (including researchers, clinicians, industry, nongovernmental organizations and funders) to expedite delivery of research results to clinical practice and improve the outcomes of difficult to treat cancers.
The American Association for Cancer Research International-Canada (AACR International-Canada), on behalf of Stand Up To Cancer Canada (SU2C Canada), and the Cancer Stem Cell Consortium (CSCC) with funding from Genome Canada and the Canadian Institutes of Health Research (CIHR), are launching a Call for Ideas for a SU2C Canada Cancer Stem Cell Dream Team Research funding opportunity.
(see the Program Guidelines for definitions of team roles and other important notes on eligibility):
- The Dream Team Leader (DTL) must be an independent researcher at a Genome Canada/CIHR eligible institution;
- The Dream Team Co-Leader must be an independent researcher at a Genome Canada/CIHR eligible institution (preferably an independent institution from a different regional jurisdiction than the DTL;
- At least four team members (other than the DTL and Co-Leader) must be independent researchers;
- At least one member must be a Young Investigator; and,
- At least one member should be an End-User and one a Patient Engagement Representative.
- $10,600,000 (Genome Canada and CIHR)
- Expected number of grants funding: One (1)
There are no indirect costs on the funding provided by Genome Canada or CIHR.
The SU2C Canada Cancer Stem Cell Dream Team will be funded for a 4-year term.
In addition to the $10,600,000 in funding provided by Genome Canada and CIHR, the Ontario Institute for Cancer Research (OICR) has made available up to $3,000,000 of supplemental funds to support clinical trial activities should the successful proposal include clinical trial activities within the Province of Ontario. Please see “SU2C Canada-OICR Cancer Clinical Trials: Canadian Dream Team Supplementary Funding” document which can be downloaded from proposalCENTRAL.
Use of Funds: The general guidelines of each of the funders must be followed (see Genome Canada and CIHR guidelines).
WEBINAR: Thursday October 30, 2014 - 1:00pm to 2:00pm EDT (English):
- Open to: Interested applicants and other stakeholders including potential funders
- Registration: To participate, please go to: https://gts-ee.webex.com, and join using the conference ID below. You will then be able to register to the Webinar.
- New Webex Conference ID
You can also join by teleconference using the following information:
- Call-in toll-free number: 1-877-413-4781
- Call-in number: 1-613-960-7510
- Conference ID: 845 565 4
If you have questions or require technical assistance please contact Olivier Jacob-Gravel at firstname.lastname@example.org.
If College-level review is required, your College will communicate its earlier internal deadlines.
How to Apply
LOI Submission Requirements: the requirements for the LOI are described in the “SU2CCanada_CSCC_Call_For_Ideas.docx” document located on the AACR International-Canada website.
Only those applicants having successfully passed the LOI stage may submit a full application.
LOIs and Full Applications must be submitted directly by the DTL on the proposalCENTRAL website by the above-noted dates/times.
If you have difficulties registering, logging in, or creating your application, contact proposalCENTRAL Customer Support: